The Effects of North Carolina’s Prescription Drug Monitoring Program on the Prescribing Behaviors of the State’s Providers

Journal of Primary Prevention

Volumn 36, Issue 2, 2015, Pages 131-137

  Ringwalt, Chris ^a   Garrettson, Mariana ^a   Alexandridis, Apostolos ^a  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

Controlled substances; Pain management; Physician prescribing behavior; Prescription drug monitoring program

Indexed keywords

CONTROLLED SUBSTANCE; NARCOTIC ANALGESIC AGENT;

ANALGESIA; CLINICAL PRACTICE; DRUG MONITORING; DRUG OVERDOSE; HUMAN; PRESCRIPTION DRUG DIVERSION; PRESCRIPTION DRUG MISUSE; PREVENTION AND CONTROL; PROCEDURES; STANDARDS; TRENDS; UNITED STATES; UTILIZATION;

ANALGESICS, OPIOID; CONTROLLED SUBSTANCES; DRUG MONITORING; DRUG OVERDOSE; HUMANS; NORTH CAROLINA; PAIN MANAGEMENT; PRACTICE PATTERNS, PHYSICIANS'; PRESCRIPTION DRUG DIVERSION; PRESCRIPTION DRUG MISUSE;

EID: 84925541836     PISSN: 0278095X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10935-014-0381-0     Document Type: Article

References (27)

1. Brennan, F., Carr, D. B., & Cousins, M. (2007). Pain management: A fundamental human right. Anesthesia and Analgesia,105, 205–221.
2. CDC. (2013). Policy impact: Prescription painkiller overdoses. Retrieved from http://www.cdc.gov/homeandrecreationalsafety/rxbrief/
3. Centers for Disease Control (CDC). (2011). Vital signs: Overdoses of prescription opioid pain relievers—United States, 1999–2008 [Vital Signs No. 60(43)] (pp. 1487–1492). Atlanta, GA: Centers for Disease Control. Retrieved from http://www.cdc.gov/mmwr/preview/mmwrhtml/mm6043a4.htm
4. Fass, J. A., & Hardigan, P. C. (2011). Attitudes of Florida pharmacists toward implementing a state prescription drug monitoring program for controlled substances. Journal of Managed Care Pharmacy,17(6), 430–438.
5. Feldman, L., Williams, K. S., Coates, J., & Knox, M. (2011). Awareness and utilization of a prescription monitoring program among physicians. Journal of Pain and Palliative Care Pharmacotherapy,25(4), 313–317.
6. Fishman, S. M., Papazian, J. S., Gonzalez, S., Riches, P. S., & Gilson, A. (2004). Regulating opioid prescribing through prescription monitoring programs: Balancing drug diversion and treatment of pain. Pain Medicine,5(3), 309–324.
7. Garcia, A. M. (2013). State laws regulating prescribing of controlled substances: Balancing the public health problems of chronic pain and prescription painkiller abuse and overdose. The Journal of Law, Medicine & Ethics,41(s1), 42–45.
8. Hernandez, S. H., & Nelson, L. S. (2010). Prescription drug abuse: Insight into the epidemic. Clinical Pharmacology and Therapeutics,88(3), 307–317.
9. Institute of Medicine (IOM). (2011). Relieving pain in America: A blueprint for transforming prevention, care, education, and research. Washington, DC: The National Academies Press.
10. Joranson, D. E., Carrow, G. M., Ryan, K. M., Schaefer, L., Gilson, A. M., Good, P.,… & Dahl, J. L. (2002). Pain management and prescription monitoring. Journal of Pain and Symptom Management, 23(3), 231–238.
11. National Alliance for Model State Drug Laws (NAMSDL). (March, 2013a). Prescription drug abuse, addiction, and diversion: Overview of state legislative and policy initiatives. Part 1: State prescription drug monitoring programs (PMPS). http://www.iowa.gov/odcp/docs/Rx%20Mon%20Programs%20NAMSDL%20March%202013.pdf
12. NAMSDL. (July, 2013b). Compilation of state prescription monitoring program maps. http://www.namsdl.org/library/13D46B1B-1372-636C-DD8A80A2928024DF/
13. National Center for Health Statistics. Bridged-race population estimates 1990–2012. Public-use data file, CDC WONDER online database. http://wonder.cdc.gov/
14. North Carolina Health Professions Data System. Annual profiles: 2009–2011 health professions tables. Cecil G. Sheps Center for Health Services Research, The University of North Carolina at Chapel Hill. http://www.shepscenter.unc.edu/hp/index.html
15. North Carolina Legislation. NC § 90-113.71(a). http://www.ncleg.net/EnactedLegislation/Statutes/HTML/ByArticle/Chapter_90/Article_5E.html
16. Paulozzi, L. J., Kilbourne, E. M., & Desai, H. A. (2011). Prescription drug monitoring programs and death rates from drug overdose. Pain Medicine,12(5), 747–754.
17. Perrone, J., & Nelson, L. S. (2012). Medication reconciliation for controlled substances—An “ideal” prescription-drug monitoring program. New England Journal of Medicine,366(25), 2341–2343.
18. Poisoning Overdose Factsheet. (January, 2013). North Carolina Division of Public Health: NC Injury and Violence Prevention Branch. http://injuryfreenc.ncdhhs.gov/About/PoisoningOverdoseFactSheet2013.pdf
19. Reifler, L. M., Droz, D., Bailey, J. E., Schnoll, S. H., Fant, R., Dart, R. C., & Bucher Bartelson, B. (2012). Do prescription monitoring programs impact state trends in opioid abuse/misuse? Pain Medicine,13(3), 434–442.
20. Reisman, R. M., Shenoy, P. J., Atherly, A. J., & Flowers, C. R. (2009). Prescription opioid usage and abuse relationships: An evaluation of state prescription drug monitoring program efficacy. Substance Abuse: Research and Treatment.,3, 41–51.
21. Simeone, R., & Holland, L. (2006). An Evaluation of Prescription Drug Monitoring Programs. Simeone Associates, Inc., No. 2005PMBXK189, September 1, 2006. http://www.simeoneassociates.com/simeone3.pdf
22. Simoni-Wastila, G. E. L. (2011). Prescription monitoring programs: Striking the balance between medical use and diversion. Journal of Addictions Nursing,22(1–2), 77–82.
23. Substance Abuse and Mental Health Services Administration. (2011). Results from the 2010 National Survey on Drug Use and Health: Summary of National Findings [No. HHS Publication No. (SMA) 11-4658]. Rockville, MD: Substance Abuse and Mental Health Services Administration. Retrieved from http://oas.samhsa.gov/NSDUH/2k10NSDUH/2k10Results.htm#2.16
24. Turk, D. C., Brody, M. C., & Okifuji, E. A. (1994). Physicians’ attitudes and practices regarding the long-term prescribing of opioids for non-cancer pain. Pain,59(2), 201–208.
25. Twillman, R. (2006). (324/995): Impact of prescription monitoring programs on prescription patterns and indicators of opioid abuse. The Journal of Pain,7(4), S6.
26. Wang, J., & Christo, P. J. (2009). The influence of prescription monitoring programs on chronic pain management. Pain Physician,12(3), 507–515.
27. Worley, J. (2012). Prescription Drug Monitoring Programs, a response to doctor shopping: Purpose, effectiveness, and directions for future research”. Issues in Mental Health Nursing,33(5), 319–328.